Cargando…
Harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (CoBiTo) in Japan
The purpose of the present study was to harmonize the protocol of equilibrium solubility measurements for poorly water-soluble drugs to lower inter-laboratory variance. The “mandatory” and “recommended” procedures for the shake-flask method were harmonized based on the knowledge and experiences of e...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Association of Physical Chemists
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957233/ https://www.ncbi.nlm.nih.gov/pubmed/35350659 http://dx.doi.org/10.5599/admet.704 |
_version_ | 1784676723573391360 |
---|---|
author | Ono, Asami Matsumura, Naoya Kimoto, Takahiro Akiyama, Yoshiyuki Funaki, Satoko Tamura, Naomi Hayashi, Shun Kojima, Yukiko Fushimi, Masahiro Sudaki, Hiroshi Aihara, Risa Haruna, Yuka Jiko, Maiko Iwasaki, Masaru Fujita, Takuya Sugano, Kiyohiko |
author_facet | Ono, Asami Matsumura, Naoya Kimoto, Takahiro Akiyama, Yoshiyuki Funaki, Satoko Tamura, Naomi Hayashi, Shun Kojima, Yukiko Fushimi, Masahiro Sudaki, Hiroshi Aihara, Risa Haruna, Yuka Jiko, Maiko Iwasaki, Masaru Fujita, Takuya Sugano, Kiyohiko |
author_sort | Ono, Asami |
collection | PubMed |
description | The purpose of the present study was to harmonize the protocol of equilibrium solubility measurements for poorly water-soluble drugs to lower inter-laboratory variance. The “mandatory” and “recommended” procedures for the shake-flask method were harmonized based on the knowledge and experiences of each company and information from the literature. The solubility of model drugs was measured by the harmonized protocol (HP) and the non-harmonized proprietary protocol of each company (nonHP). Albendazole, griseofulvin, dipyridamole, and glibenclamide were used as model drugs. When using the nonHP, the solubility values showed large inter-laboratory variance. In contrast, inter-laboratory variance was markedly reduced when using the HP. |
format | Online Article Text |
id | pubmed-8957233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | International Association of Physical Chemists |
record_format | MEDLINE/PubMed |
spelling | pubmed-89572332022-03-28 Harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (CoBiTo) in Japan Ono, Asami Matsumura, Naoya Kimoto, Takahiro Akiyama, Yoshiyuki Funaki, Satoko Tamura, Naomi Hayashi, Shun Kojima, Yukiko Fushimi, Masahiro Sudaki, Hiroshi Aihara, Risa Haruna, Yuka Jiko, Maiko Iwasaki, Masaru Fujita, Takuya Sugano, Kiyohiko ADMET DMPK Original Scientific Paper The purpose of the present study was to harmonize the protocol of equilibrium solubility measurements for poorly water-soluble drugs to lower inter-laboratory variance. The “mandatory” and “recommended” procedures for the shake-flask method were harmonized based on the knowledge and experiences of each company and information from the literature. The solubility of model drugs was measured by the harmonized protocol (HP) and the non-harmonized proprietary protocol of each company (nonHP). Albendazole, griseofulvin, dipyridamole, and glibenclamide were used as model drugs. When using the nonHP, the solubility values showed large inter-laboratory variance. In contrast, inter-laboratory variance was markedly reduced when using the HP. International Association of Physical Chemists 2019-08-05 /pmc/articles/PMC8957233/ /pubmed/35350659 http://dx.doi.org/10.5599/admet.704 Text en Copyright © 2019 by the authors. https://creativecommons.org/licenses/by/3.0/This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ). |
spellingShingle | Original Scientific Paper Ono, Asami Matsumura, Naoya Kimoto, Takahiro Akiyama, Yoshiyuki Funaki, Satoko Tamura, Naomi Hayashi, Shun Kojima, Yukiko Fushimi, Masahiro Sudaki, Hiroshi Aihara, Risa Haruna, Yuka Jiko, Maiko Iwasaki, Masaru Fujita, Takuya Sugano, Kiyohiko Harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (CoBiTo) in Japan |
title | Harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (CoBiTo) in Japan |
title_full | Harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (CoBiTo) in Japan |
title_fullStr | Harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (CoBiTo) in Japan |
title_full_unstemmed | Harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (CoBiTo) in Japan |
title_short | Harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (CoBiTo) in Japan |
title_sort | harmonizing solubility measurement to lower inter-laboratory variance – progress of consortium of biopharmaceutical tools (cobito) in japan |
topic | Original Scientific Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957233/ https://www.ncbi.nlm.nih.gov/pubmed/35350659 http://dx.doi.org/10.5599/admet.704 |
work_keys_str_mv | AT onoasami harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT matsumuranaoya harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT kimototakahiro harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT akiyamayoshiyuki harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT funakisatoko harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT tamuranaomi harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT hayashishun harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT kojimayukiko harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT fushimimasahiro harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT sudakihiroshi harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT aihararisa harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT harunayuka harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT jikomaiko harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT iwasakimasaru harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT fujitatakuya harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan AT suganokiyohiko harmonizingsolubilitymeasurementtolowerinterlaboratoryvarianceprogressofconsortiumofbiopharmaceuticaltoolscobitoinjapan |